NeoGenomics to Participate in Upcoming Investor Conferences
NeoGenomics Reports Fourth Quarter and Full Year 2025 Results
NeoGenomics Introduces PanTracer Pro to Support Timely, Informed Solid Tumor Therapy Selection
San Francisco, California
